IL1B and type 2 diabetes mellitus: In conclusion, the present work provided an evidence in a T2DM mouse model that IL-1β blockage is effective in treating T2DM, further suggesting that active immunization targeting IL-1β may be a potential therapeutic for T2DM treatment.